Lincoln Pharma Sets Record Date Sept 11 for 32nd AGM & 18% Final Dividend
Lincoln Pharmaceuticals Limited announced the record date as September 11, 2026, for its 32nd AGM and a final dividend. The AGM is on September 30, 2026. The company proposed an 18% final dividend (₹ 1.80 per share) for FY26.
The declaration of a dividend and the scheduling of an AGM are routine corporate events. While positive, the impact is considered medium as it does not represent a significant new business development or financial performance change.
The announcement of a final dividend is generally perceived as positive by shareholders as it represents a return on their investment.
Lincoln Pharmaceuticals Limited has announced the record date for its 32nd Annual General Meeting (AGM) and the final dividend for the financial year 2025-26. The AGM is scheduled to be held on Wednesday, September 30, 2026, at 11:00 a.m. IST, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
The record date for determining shareholders' entitlement to the final dividend, if approved at the AGM, has been set as Friday, September 11, 2026. The book closure will commence on Saturday, September 12, 2026, and conclude on Wednesday, September 30, 2026.
The company has proposed a final dividend of 18%, amounting to ₹ 1.80 per equity share of face value ₹ 10 each. This dividend pertains to the financial year April 01, 2025, to March 31, 2026, and is payable subject to the approval of the members at the upcoming AGM.
A plain-language summary of a public exchange filing by Lincoln Pharmaceuticals Limited. Read the original for the full detail.